Literature DB >> 22984111

Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.

Maree Teesson1, Tim Slade, Wendy Swift, Katherine Mills, Sonja Memedovic, Louise Mewton, Rachel Grove, Nicola Newton, Wayne Hall.   

Abstract

OBJECTIVE: To report nationally representative findings on the prevalence, correlates, psychiatric comorbidity and treatment of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.
METHOD: The 2007 National Survey of Mental Health and Wellbeing was a nationally representative household survey of 8841 Australians (16-85 years) that assessed symptoms of the most prevalent DSM-IV mental disorders.
RESULTS: Prevalence of lifetime and 12-month cannabis use was 18% and 6%; prevalence of lifetime and 12-month cannabis use disorder was 6% and 1%. The conditional prevalence (proportion of ever users who met criteria for a disorder) of lifetime and 12-month cannabis use disorder was 32.2% and 14.3%. Current cannabis use disorders were more common in males (OR 2.0) and younger users (OR 4.6). Strong associations were observed between current cannabis use disorders and alcohol use disorders (OR 3.6) and current affective disorders (OR 3.0). Only 36.2% of those with current cannabis use disorders sought any treatment.
CONCLUSIONS: The prevalence of cannabis use disorders in the Australian population is comparable with that in the USA. Current cannabis use disorders are highly concentrated in young Australians who have high levels of comorbidity. The low rates of treatment seeking warrant attention in treatment and prevention strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22984111     DOI: 10.1177/0004867412460591

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  22 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

2.  Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Authors:  Didier Jutras-Aswad; Bernard Le Foll; Julie Bruneau; T Cameron Wild; Evan Wood; Benedikt Fischer
Journal:  Can J Psychiatry       Date:  2018-07-22       Impact factor: 4.356

Review 3.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

4.  Cannabis-Related Impairment and Social Anxiety: The Role of Use to Manage Negative and Positive Affect in Social Situations.

Authors:  Katherine Walukevich-Dienst; Elizabeth M Lewis; Julia D Buckner
Journal:  Subst Use Misuse       Date:  2019-09-19       Impact factor: 2.164

5.  Cannabis Use in Adolescence and Young Adulthood: A Review of Findings from the Victorian Adolescent Health Cohort Study.

Authors:  Carolyn Coffey; George C Patton
Journal:  Can J Psychiatry       Date:  2016-06       Impact factor: 4.356

6.  Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.

Authors:  Julia D Buckner; Michael J Zvolensky; Anthony H Ecker; Norman B Schmidt; Elizabeth M Lewis; Daniel J Paulus; Paula Lopez-Gamundi; Kathleen A Crapanzano; Jafar Bakhshaie
Journal:  Behav Res Ther       Date:  2018-10-26

7.  Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.

Authors:  Meenakshi Sabina Subbaraman; Jane Metrik; Deidre Patterson; Robert Swift
Journal:  Addiction       Date:  2017-01-10       Impact factor: 6.526

8.  Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Deborah S Hasin; Bradley T Kerridge; Tulshi D Saha; Boji Huang; Roger Pickering; Sharon M Smith; Jeesun Jung; Haitao Zhang; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2016-03-04       Impact factor: 18.112

Review 9.  Psychosocial interventions for cannabis use disorder.

Authors:  Peter J Gates; Pamela Sabioni; Jan Copeland; Bernard Le Foll; Linda Gowing
Journal:  Cochrane Database Syst Rev       Date:  2016-05-05

10.  Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies.

Authors:  M Taylor; J Cousijn; F Filbey
Journal:  Curr Addict Rep       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.